Suchergebnisse - "Shinoda, Masahiro"

PubPharm (35)

1

Surveillance of seasonal influenza viruses during the COVID-19 pandemic in Tokyo, Japan, 2018-2023, a single-center study

enthalten in: Influenza and other respiratory viruses | 2024

von Takahashi, H. | Nagamatsu, H. | Yamada, Y. | +11

2

Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain

enthalten in: Nature communications | 2023

von Takano, T. | Sato, T. | Kotaki, R. | +13

3

A case of reinfection with a different variant of SARS-CoV-2: case report

enthalten in: The Egyptian Journal of Internal Medicine | 2023

von Shimada, N. | Shinoda, M. | Takei, H. | +7

4

A case of reinfection with a different variant of SARS-CoV-2: case report

enthalten in: The Egyptian Journal of Internal Medicine | 2023

von Shimada, N. | Shinoda, M. | Takei, H. | +7

5

A case of reinfection with a different variant of SARS-CoV-2 : case report

enthalten in: The Egyptian journal of internal medicine | 2023

von Shimada, N. | Shinoda, M. | Takei, H. | +7

6

High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19 : A Single Center, retrospective, Propensity Score-Matched Case-Control Study

enthalten in: International journal of general medicine | 2023

von Shinoda, M. | Ota, S. | Yoshida, Y. | +6

7

Possibility of underestimation of COVID-19 prevalence by PCR and serological tests

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2022

von Ota, S. | Sugawa, S. | Suematsu, E. | +3

8

Correction : A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

ErratumFor: BMC Med. 2022 Sep 27;20(1):342. - PMID 36163020

9

Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

10

Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11